Aliases & Classifications for Postherpetic Neuralgia

MalaCards integrated aliases for Postherpetic Neuralgia:

Name: Postherpetic Neuralgia 54 37 73

External Ids:

KEGG 37 H01624
UMLS 73 C0032768

Summaries for Postherpetic Neuralgia

NINDS : 54 Shingles (herpes zoster) is an outbreak of rash or blisters on the skin that is caused by the same virus that causes chickenpox — the varicella-zoster virus. The first sign of shingles is often burning or tingling pain (which can be severe), or sometimes numbness or itch,generally on one side of the body. After several days or a week, a rash of fluid-filled blisters, similar to chickenpox, appears in one area on one side of the body. Shingles pain can be mild or intense.  Some people have mostly itching; some feel pain from the gentlest touch or breeze.  The most common location for shingles is a band, called a dermatome, spanning one side of the trunk around the waistline. Anyone who has had chickenpox is at risk for shingles.  Scientists think that some of the virus particles from the original exposure to the varicella-zoster virus,leave the skin blisters and move into the nervous system.  When the varicella-zoster virus reactivates, the virus moves back down the long nerve fibers that extend from the sensory cell bodies to the skin.  The viruses multiply, the tell-tale rash erupts, and the person now has shingles.

MalaCards based summary : Postherpetic Neuralgia is related to herpes zoster and neuropathy, and has symptoms including neuralgia and sciatica. An important gene associated with Postherpetic Neuralgia is HLA-B (Major Histocompatibility Complex, Class I, B), and among its related pathways/superpathways are Class I MHC mediated antigen processing and presentation and Cytokine Signaling in Immune system. The drugs Lidocaine and Foscarnet have been mentioned in the context of this disorder. Affiliated tissues include skin, brain and spinal cord, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Wikipedia : 76 Postherpetic neuralgia (PHN) is nerve pain which occurs due to damage to a peripheral nerve caused by... more...

Related Diseases for Postherpetic Neuralgia

Diseases related to Postherpetic Neuralgia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 88)
# Related Disease Score Top Affiliating Genes
1 herpes zoster 11.8
2 neuropathy 10.6
3 peripheral nervous system disease 10.4
4 diabetic neuropathy 10.4
5 aging 10.3
6 herpes zoster ophthalmicus 10.2
7 cervicitis 10.2
8 neuronitis 10.2
9 trigeminal neuralgia 10.1
10 microscopic polyangiitis 10.0 HLA-B HLA-DRB1
11 idiopathic inflammatory myopathy 10.0 HLA-B HLA-DRB1
12 polyneuropathy 10.0
13 spinal cord injury 10.0
14 peptic ulcer disease 10.0
15 acute disseminated encephalomyelitis 10.0 HLA-B HLA-DRB1
16 panuveitis 10.0 HLA-B HLA-DRB1
17 echinococcosis 10.0 HLA-B HLA-DRB1
18 sclerosing cholangitis 9.9 HLA-B HLA-DRB1
19 rheumatoid arthritis 9.9
20 horner's syndrome 9.9
21 herpes simplex 9.9
22 diabetic polyneuropathy 9.9
23 chickenpox 9.9
24 galactorrhea 9.9
25 paine syndrome 9.9
26 dermatitis 9.9
27 fibromyalgia 9.9
28 coronary heart disease 1 9.9
29 contact dermatitis 9.9
30 back pain 9.9
31 anxiety 9.9
32 vestibular disease 9.9
33 chronic pain 9.9
34 arthritis 9.9
35 cerebritis 9.9
36 headache 9.9
37 brain injury 9.9
38 radiculopathy 9.9
39 myoclonus 9.9
40 chronic kidney failure 9.9
41 kidney disease 9.9
42 neurotrophic keratopathy 9.9
43 keratopathy 9.9
44 spondylitis 9.9
45 axonal neuropathy 9.9
46 traumatic brain injury 9.9
47 epidural abscess 9.9
48 heart disease 9.9
49 cholangitis 9.9 HLA-B HLA-DRB1
50 rheumatic disease 9.8 HLA-B HLA-DRB1

Graphical network of the top 20 diseases related to Postherpetic Neuralgia:



Diseases related to Postherpetic Neuralgia

Symptoms & Phenotypes for Postherpetic Neuralgia

UMLS symptoms related to Postherpetic Neuralgia:


neuralgia, sciatica

GenomeRNAi Phenotypes related to Postherpetic Neuralgia according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-103 10.53 HLA-B HLA-A
2 Increased shRNA abundance (Z-score > 2) GR00366-A-110 10.53 HLA-A HLA-B
3 Increased shRNA abundance (Z-score > 2) GR00366-A-118 10.53 HLA-A HLA-B
4 Increased shRNA abundance (Z-score > 2) GR00366-A-156 10.53 HLA-A HLA-B
5 Increased shRNA abundance (Z-score > 2) GR00366-A-178 10.53 HLA-B HLA-A
6 Increased shRNA abundance (Z-score > 2) GR00366-A-19 10.53 HLA-B HLA-A
7 Increased shRNA abundance (Z-score > 2) GR00366-A-31 10.53 HLA-B HLA-A
8 Increased shRNA abundance (Z-score > 2) GR00366-A-7 10.53 HLA-B HLA-A
9 Increased shRNA abundance (Z-score > 2) GR00366-A-74 10.53 HLA-B HLA-A

Drugs & Therapeutics for Postherpetic Neuralgia

Drugs for Postherpetic Neuralgia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 170)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 137-58-6 3676
2
Foscarnet Approved Phase 4 63585-09-1, 4428-95-9 3415
3
Etoricoxib Approved, Investigational Phase 4,Phase 2 202409-33-4 123619
4
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2,Phase 1 148553-50-8 5486971
5
Acyclovir Approved Phase 4,Phase 3,Phase 2,Not Applicable 59277-89-3 2022
6
Furosemide Approved, Vet_approved Phase 4 54-31-9 3440
7
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
8
Acetylcholine Approved Phase 4,Phase 2 51-84-3 187
9
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
10
Carbamazepine Approved, Investigational Phase 4 298-46-4 2554
11
Gabapentin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 60142-96-3 3446
12
Capsaicin Approved Phase 4,Phase 3,Phase 2,Phase 1 404-86-4 1548943
13
Acetaminophen Approved Phase 4 103-90-2 1983
14
Chlorhexidine Approved, Vet_approved Phase 4 55-56-1 9552079 2713
15
Oxcarbazepine Approved Phase 4 28721-07-5 34312
16
gamma-Aminobutyric acid Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 56-12-2 119
17
Phosphonoacetic Acid Experimental Phase 4 4408-78-0 546
18 Analgesics Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
19 calcium channel blockers Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
20 diuretics Phase 4,Phase 1,Phase 2
21 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
22 Reverse Transcriptase Inhibitors Phase 4
23 Narcotics Phase 4,Phase 2,Phase 3,Not Applicable
24 Natriuretic Agents Phase 4,Phase 1,Phase 2
25 Sodium Channel Blockers Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
26 Cyclooxygenase 2 Inhibitors Phase 4,Phase 2
27 Cyclooxygenase Inhibitors Phase 4,Phase 2,Phase 1,Not Applicable
28 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 1,Not Applicable
29 Analgesics, Opioid Phase 4,Phase 2,Phase 3,Not Applicable
30 Anesthetics Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
31 Nucleic Acid Synthesis Inhibitors Phase 4
32 Anesthetics, Local Phase 4,Phase 2,Phase 1,Not Applicable
33 Tranquilizing Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
34 Diuretics, Potassium Sparing Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
35 Anti-Anxiety Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
36 Anti-Arrhythmia Agents Phase 4,Phase 2,Phase 1,Not Applicable
37 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
38 Anticonvulsants Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
39 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Not Applicable
40 Anti-Inflammatory Agents Phase 4,Phase 2,Phase 1,Not Applicable
41 Anti-Retroviral Agents Phase 4
42 Psychotropic Drugs Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
43 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 2,Phase 1,Not Applicable
44 Antirheumatic Agents Phase 4,Phase 2,Phase 1,Not Applicable
45 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
46 Calcium, Dietary Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
47 Chlorhexidine gluconate Phase 4
48 abobotulinumtoxinA Phase 4,Phase 2
49 Cholinergic Agents Phase 4,Phase 2
50 GABA Agents Phase 4,Phase 3,Phase 2,Not Applicable

Interventional clinical trials:

(show top 50) (show all 197)
# Name Status NCT ID Phase Drugs
1 Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain Unknown status NCT01264237 Phase 4 Etoricoxib;Placebo
2 Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster Unknown status NCT02151240 Phase 4 Foscarnet Sodium;Acyclovir
3 Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN) Completed NCT01455428 Phase 4 Lyrica (pregabalin);Placebo
4 A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia Completed NCT00629681 Phase 4 Pregabalin
5 Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia Completed NCT00159666 Phase 4 pregabalin
6 A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain Completed NCT00904020 Phase 4 Lidoderm
7 Pregabalin Treatment Of Peripheral Neuropathic Pain Associated With Diabetic Peripheral NeP (DPN), Postherpetic Neuralgia (PHN), HIV-related NeP (HIV), and Chemotherapy Induced NeP Completed NCT00407511 Phase 4 Pregabalin
8 Efficacy Study of Botox to Treat Neuropathic Pain Completed NCT00527202 Phase 4 botulinum toxin A and saline
9 A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment Completed NCT01713426 Phase 4 Qutenza;Pregabalin
10 Botulinum Toxin in Peripheral Neuropathic Pain Completed NCT01251211 Phase 4 botulinum toxin type A
11 LPHP-Philos-PHN Conservative Treatment Completed NCT00205959 Phase 4
12 A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions Completed NCT00904202 Phase 4 Placebo Capsules + Placebo Patch;Placebo capsules + Lidoderm®;Gabapentin + Placebo;Gabapentin + Lidoderm®;Gabapentin 300 mg capsules 1800 mg/day + placebo patch;Gabapentin 1800 mg/day + Lidoderm patch
13 Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch Completed NCT01416116 Phase 4 QUTENZA;Lidocaine;Tramadol
14 Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain Completed NCT01302275 Phase 4 Oxcarbazepine
15 Early Diuresis Following Colorectal Surgery Completed NCT02351934 Phase 4 Furosemide;Celecoxib;Gabapentin
16 Dressing: Frequency of Change and Evaluation of an Antiseptic-Impregnated Catheter Dressing in ICU Patients Completed NCT00417235 Phase 4
17 Acupuncture in Herpes Zoster Neuralgia (ACUZoster) Active, not recruiting NCT00885586 Phase 4 gabapentine
18 Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia Terminated NCT01603394 Phase 4 pregabalin
19 Preemptive Analgesia Following Uterine Artery Embolization Terminated NCT01555073 Phase 4 pregabalin/celecoxib;pregabalin/placebo;celecoxib/placebo;Placebo group
20 Efficacy, Safety, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or Pregabalin Withdrawn NCT01116531 Phase 4 Tramadol;Duloxetine;Pregabalin
21 Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic Neuralgia Unknown status NCT02868801 Phase 3 Placebo;Pregabalin SR tablet 165mg/day;Pregabalin SR tablet 330mg/day;Pregabalin SR tablet 660mg/day
22 Study of PHN131 in Patients After Surgery Unknown status NCT02193620 Phase 2, Phase 3 PHN131 soft capsule with Nalbuphine HCl 60 mg/cap;Placebo soft capsules;Dicofenac
23 Effect of Opioids in Neuropathic Pain in Postherpetic Patients Unknown status NCT01102101 Phase 3 Remifentanil
24 A Novel Non Invasive Brain Stimulation Based Treatment for Chronic Low Back Pain (CLBP) Unknown status NCT02393391 Phase 2, Phase 3
25 Methadone in Post-Herpetic Neuralgia Pain Completed NCT01752699 Phase 3 Methadone;Placebo
26 Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia Completed NCT01270828 Phase 3 Pregabalin;placebo
27 Safety and Efficacy of Gabapentin in Postherpetic Neuralgia Completed NCT00335933 Phase 3 Gabapentin extended-release tablets
28 Safety and Efficacy of Gabapentin in Postherpetic Neuralgia Completed NCT00636636 Phase 3 Gabapentin Extended Release tablets;Placebo
29 A Confirmatory Study of Fentanyl in Participants With Post-herpetic Neuralgia, Complex Regional Pain Syndrome or Postoperative Pain Syndrome Completed NCT01008553 Phase 3 Fentanyl;Placebo
30 DS-5565 Phase III Study for Renal Impairment in Japanese Subjects Completed NCT02607280 Phase 3 DS-5565
31 Study of NGX-4010 for the Treatment of Postherpetic Neuralgia Completed NCT00300222 Phase 3 NGX-4010
32 Study of NGX-4010 for the Treatment of Postherpetic Neuralgia Completed NCT00115310 Phase 3 NGX-4010
33 To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia. Completed NCT00150436 Phase 3 Pregabalin
34 A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia Completed NCT00394901 Phase 3 Placebo;Pregabalin;Pregabalin;Pregabalin
35 Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia Completed NCT00377598 Phase 2, Phase 3 TAK-583;TAK-583;TAK-583;TAK-583;Placebo
36 NGX-4010 for the Treatment of Postherpetic Neuralgia Completed NCT00061776 Phase 2, Phase 3 Capsaicin Dermal Patch
37 Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN) Completed NCT00592904 Phase 2, Phase 3 E2007
38 Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia Completed NCT00068081 Phase 3 Capsaicin Dermal Patch
39 Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain Completed NCT00414349 Phase 3 Topical analgesic;oral intake;Topical analgesic
40 A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia Completed NCT00424372 Phase 3 pregabalin
41 Shingles Prevention Study Completed NCT00007501 Phase 3
42 Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic Neuralgia Completed NCT00004390 Phase 3 desipramine;methadone;morphine;nortriptyline
43 Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older Completed NCT01165229 Phase 3
44 Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy Completed NCT01332149 Phase 3 Pregabalin;Placebo matched with pregabalin
45 Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain. Completed NCT00219544 Phase 3 Pregabalin (Lyrica);Pregabalin (Lyrica);Pregabalin (Lyrica);Placebo
46 A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001) Completed NCT01229267 Phase 3
47 A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011) Completed NCT01254630 Phase 3
48 Effect of Oral Pregabalin on Spinal Neurotransmitters in Patients Undergoing Knee Replacement Completed NCT00729690 Phase 3 Pregabalin;Pregabalin;Placebo
49 Postoperative Pain and Morphine Consumption After Mastectomy - Lyrica Completed NCT01391858 Phase 3 lyrica
50 Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections ( Completed NCT01650051 Phase 3 Placebo of Phenazopyridine Hydrochloride Tables, USP 200 mg;Phenazopyridine Hydrochloride Tables, USP 200 mg

Search NIH Clinical Center for Postherpetic Neuralgia

Genetic Tests for Postherpetic Neuralgia

Anatomical Context for Postherpetic Neuralgia

MalaCards organs/tissues related to Postherpetic Neuralgia:

41
Skin, Brain, Spinal Cord, Testes, Endothelial, Liver, Dorsal Root Ganglion

Publications for Postherpetic Neuralgia

Articles related to Postherpetic Neuralgia:

(show top 50) (show all 631)
# Title Authors Year
1
Associations of Perceived Mental Stress, Sense of Purpose in Life, and Negative Life Events With the Risk of Incident Herpes Zoster and Postherpetic Neuralgia: The SHEZ Study. ( 29036443 )
2018
2
Epidemiology and long-term disease burden of herpes zoster and postherpetic neuralgia in Taiwan: a population-based, propensity score-matched cohort study. ( 29554872 )
2018
3
Sensory symptom profiles differ between trigeminal and thoracolumbar postherpetic neuralgia. ( 29430564 )
2018
4
Usefulness of Inflammatory Markers for the Prediction of Postherpetic Neuralgia in Patients with Acute Herpes Zoster. ( 29606812 )
2018
5
Herpes zoster chronification to postherpetic neuralgia induces brain activity and grey matter volume change. ( 29423004 )
2018
6
Effect of Tetrodotoxin Pellets in a Rat Model of Postherpetic Neuralgia. ( 29874779 )
2018
7
Effectiveness of continuous epidural analgesia on acute herpes zoster and postherpetic neuralgia: A retrospective study. ( 29384888 )
2018
8
Impact of postherpetic neuralgia: A six year population-based analysis on people aged 50 years or older. ( 29742472 )
2018
9
Pecs II block for intractable postherpetic neuralgia. ( 29696382 )
2018
10
Efficacy of Pain Relief in Different Postherpetic Neuralgia Therapies: A Network Meta-Analysis. ( 29357328 )
2018
11
Treatment of Postherpetic Neuralgia With Intravenous Administration of Zinc Sulfate: A Case Report. ( 29634548 )
2018
12
Neurotrophic Keratopathy after Trigeminal Nerve Block for Treatment of Postherpetic Neuralgia. ( 29955409 )
2018
13
Combined therapy of pulsed radiofrequency and nerve block in postherpetic neuralgia patients: a randomized clinical trial. ( 29888123 )
2018
14
Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged a8Y50 years: A prospective study. ( 29428228 )
2018
15
The Analgesic and Emotional Response to Intravenous Lidocaine Infusion in the Treatment of Postherpetic Neuralgia: A Randomized, Double-Blinded, Placebo-Controlled Study. ( 29698250 )
2018
16
Altered functional connectivity density in patients with herpes zoster and postherpetic neuralgia. ( 29740216 )
2018
17
Postherpetic Neuralgia ( 29630250 )
2018
18
Subcutaneous Injection of Botulinum Toxin-A in Postherpetic Neuralgia During Pregnancy. ( 29184352 )
2017
19
Subcutaneous Injection of Triamcinolone and Lidocaine to Prevent Postherpetic Neuralgia. ( 28727702 )
2017
20
Glucocorticoids - Efficient analgesics against postherpetic neuralgia? ( 28850413 )
2017
21
White matter microstructure degenerates in patients with postherpetic neuralgia. ( 28729077 )
2017
22
Herpes Zoster and Postherpetic Neuralgia: Prevention and Management. ( 29431387 )
2017
23
Effect of Concomitant Pain Medications on Response to Pregabalin in Patients with Postherpetic Neuralgia or Spinal Cord Injury-Related Neuropathic Pain. ( 28072797 )
2017
24
Postherpetic neuralgia, diabetic neuropathy, and trigeminal neuralgia - Chronic peripheral neuropathic pain in 58,480 rural Italian primary care patients. ( 29026761 )
2017
25
Ultrasound-Guided Selective Cervical Root Injection for Postherpetic Neuralgia. ( 28346307 )
2017
26
Postherpetic Neuralgia Presenting as Delusional Parasitosis: A Case Series. ( 28615772 )
2017
27
Neuromodulation in Postherpetic Neuralgia: Case Reports and Review of the Literature. ( 29016994 )
2017
28
Comparing serum microRNA levels of acute herpes zoster patients with those of postherpetic neuralgia patients. ( 28225487 )
2017
29
PainVisionAr Apparatus for Assessment of Efficacy of Pulsed Radiofrequency Combined with Pharmacological Therapy in the Treatment of Postherpetic Neuralgia and Correlations with Measurements. ( 28357404 )
2017
30
The Effect of Early Use of Supplemental Therapy on Preventing Postherpetic Neuralgia: A Systematic Review and Meta-analysis. ( 28934778 )
2017
31
Treatment Option for Refractory Postherpetic Neuralgia - Transversus Abdominis Plane (TAP) Block: Two Case Reports. ( 28920039 )
2017
32
Effect of Single Intra-cutaneous Injection for Acute Thoracic Herpes Zoster and Incidence of Postherpetic Neuralgia. ( 29153295 )
2017
33
Glossopharyngeal Postherpetic Neuralgia Palliated With Fluoroscopic-Guided Nerve Block: A Case Report. ( 28925505 )
2017
34
Effect of Zhuang medicine medicated thread moxibustion on protomics in serum of postherpetic neuralgia patient with Herpes zoster. ( 28671082 )
2017
35
Association of serum Ninjurin2 levels with neurologic damage and postherpetic neuralgia occurrence: an observational cohort study in chinese herpeszoster patients. ( 29069724 )
2017
36
Dose-response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia. ( 28967801 )
2017
37
Pulsed Radiofrequency to the Dorsal Root Ganglion in Acute Herpes Zoster and Postherpetic Neuralgia. ( 28339440 )
2017
38
Postherpetic neuralgia: New hopes in prevention with adult vaccination and in treatment with a concentrated capsaicin patch. ( 29913873 )
2017
39
Postherpetic Neuralgia: Practical Experiences Return to Traditional Chinese Medicine. ( 28712474 )
2017
40
Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia. ( 28086817 )
2017
41
Postherpetic Neuralgia and Trigeminal Neuralgia. ( 29359044 )
2017
42
The life long burden of suffering from postherpetic neuralgia is reduced by adult vaccination and by topical anti-hyperalgesic treatment with lidocaine and capsaicin. ( 29913865 )
2017
43
Transdermal oxycodone patch for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled trial. ( 28415907 )
2017
44
Safety and Efficacy of a Topical Sodium Channel Inhibitor (TV-45070) in Patients With Postherpetic Neuralgia (PHN): A Randomized, Controlled, Proof-of-Concept, Crossover Study, With a Subgroup Analysis of the Nav1.7 R1150W Genotype. ( 28266963 )
2017
45
Abnormal Local Brain Activity Beyond the Pain Matrix in Postherpetic Neuralgia Patients: A Resting-State Functional MRI Study. ( 28158166 )
2017
46
Botulinum Toxin A Might Be an Alternative or Adjunct Therapy for the Treatment of Trigeminal and Postherpetic Neuralgia. ( 28865822 )
2017
47
Treatment patterns of postherpetic neuralgia patients before and after the launch of pregabalin and its effect on medical costs: Analysis of Japanese claims data provided by Japan Medical Data Center. ( 28256737 )
2017
48
Local Brain Activity Differences Between Herpes Zoster and Postherpetic Neuralgia Patients: A Resting-State Functional MRI Study. ( 28727713 )
2017
49
Earlier treatment improves the chances of complete relief from postherpetic neuralgia. ( 28757922 )
2017
50
TREATMENT OF POSTHERPETIC NEURALGIA WITH 5% TOPICAL LIDOCAINE PLASTER a89 EXPERIENCE FROM A SMALL COUNTY HOSPITAL: CASE REPORT. ( 29117658 )
2016

Variations for Postherpetic Neuralgia

Expression for Postherpetic Neuralgia

Search GEO for disease gene expression data for Postherpetic Neuralgia.

Pathways for Postherpetic Neuralgia

Pathways related to Postherpetic Neuralgia according to GeneCards Suite gene sharing:

(show all 20)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.91 HLA-A HLA-B HLA-DRB1
2
Show member pathways
12.82 HLA-A HLA-B HLA-DRB1
3
Show member pathways
12.44 HLA-A HLA-B HLA-DRB1
4
Show member pathways
12.37 HLA-A HLA-B HLA-DRB1
5
Show member pathways
12.27 HLA-A HLA-B HLA-DRB1
6
Show member pathways
12.19 HLA-A HLA-B
7
Show member pathways
12.06 HLA-A HLA-B
8
Show member pathways
12.02 HLA-A HLA-B
9
Show member pathways
11.99 HLA-A HLA-B HLA-DRB1
10 11.95 HLA-A HLA-B
11 11.85 HLA-A HLA-B
12 11.84 HLA-A HLA-B HLA-DRB1
13 11.73 HLA-A HLA-B
14 11.64 HLA-A HLA-B
15 11.64 HLA-A HLA-B HLA-DRB1
16
Show member pathways
11.55 HLA-A HLA-DRB1
17
Show member pathways
11.51 HLA-A HLA-DRB1
18 11.31 HLA-A HLA-B HLA-DRB1
19 10.96 HLA-A HLA-B HLA-DRB1
20 10.77 HLA-A HLA-B

GO Terms for Postherpetic Neuralgia

Cellular components related to Postherpetic Neuralgia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 endoplasmic reticulum GO:0005783 9.65 HLA-A HLA-B HLA-DRB1
2 Golgi apparatus GO:0005794 9.63 HLA-A HLA-B HLA-DRB1
3 cell surface GO:0009986 9.5 HLA-A HLA-B HLA-DRB1
4 early endosome membrane GO:0031901 9.43 HLA-A HLA-B
5 Golgi membrane GO:0000139 9.43 HLA-A HLA-B HLA-DRB1
6 recycling endosome membrane GO:0055038 9.4 HLA-A HLA-B
7 phagocytic vesicle membrane GO:0030670 9.37 HLA-A HLA-B
8 MHC class I protein complex GO:0042612 9.16 HLA-A HLA-B
9 ER to Golgi transport vesicle membrane GO:0012507 9.13 HLA-A HLA-B HLA-DRB1
10 integral component of lumenal side of endoplasmic reticulum membrane GO:0071556 8.8 HLA-A HLA-B HLA-DRB1

Biological processes related to Postherpetic Neuralgia according to GeneCards Suite gene sharing:

(show all 11)
# Name GO ID Score Top Affiliating Genes
1 immune system process GO:0002376 9.61 HLA-A HLA-B HLA-DRB1
2 immune response GO:0006955 9.58 HLA-A HLA-B HLA-DRB1
3 viral process GO:0016032 9.54 HLA-A HLA-B HLA-DRB1
4 regulation of immune response GO:0050776 9.49 HLA-A HLA-B
5 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent GO:0002479 9.48 HLA-A HLA-B
6 type I interferon signaling pathway GO:0060337 9.46 HLA-A HLA-B
7 antigen processing and presentation of peptide antigen via MHC class I GO:0002474 9.32 HLA-A HLA-B
8 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent GO:0002480 9.26 HLA-A HLA-B
9 protection from natural killer cell mediated cytotoxicity GO:0042270 9.16 HLA-A HLA-B
10 interferon-gamma-mediated signaling pathway GO:0060333 9.13 HLA-A HLA-B HLA-DRB1
11 antigen processing and presentation GO:0019882 8.8 HLA-A HLA-B HLA-DRB1

Molecular functions related to Postherpetic Neuralgia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 peptide antigen binding GO:0042605 8.8 HLA-A HLA-B HLA-DRB1

Sources for Postherpetic Neuralgia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....